Maximize Your Impact At ESMO Targeted Anticancer Therapies Congress 2026
The ESMO Targeted Anticancer Therapies Congress 2026, held on March 16, 2026, at the Palais des Congrès in Paris, brings together leaders in oncology drug development, translational science, and precision medicine. This influential event serves as a concentrated forum for top pharmaceutical executives, biotech innovators, and clinical researchers actively shaping the future of targeted cancer treatment. The congress enables strategic discussions around emerging therapies, compound evaluations, and clinical trial collaborations, making it a key gathering point for those involved in oncology pipelines and partnership decisions.
Attendees include senior executives, R&D directors, medical affairs leaders, and investment decision-makers from leading pharmaceutical companies, academic institutions, and disruptive biotech firms. With such decision-rich attendance, the congress is a prime opportunity to surface early partnership conversations, respond to capital allocation strategies, and align with clinical development priorities. Having access to an enriched attendee list ahead of time helps your team connect meaningfully with the right stakeholders before their calendars fill, ensuring timely, productive conversations that continue after the event.
How Sales, Marketing and Revops Teams Can Use This Attendee List
The ESMO Targeted Anticancer Therapies Congress attendee data is especially valuable for commercial, scientific, and business development teams focused on oncology innovation. Use the enriched attendee list to prioritize contacts from biotech startups, pharmaceutical manufacturers, CROs, and research institutions. Segment contacts by function—such as translational R&D, regulatory affairs, or clinical operations—to tailor outreach to their area of responsibility.
Book early meetings using verified contact details to position yourself as a collaborator, not just a vendor. Align messaging with current focus areas like novel biomarker validation, immunotherapy pipelines, or clinical-stage compounds. During the congress, identify in-person meetings with budget stakeholders and scientific collaborators. After the event, follow up with insights tied directly to what they engaged with—such as matched trial case studies, co-development potentials, or regulatory planning tools—turning brief conversations into ongoing evaluations or joint initiatives.
If you’re looking for how to get more meetings in a high-stakes environment like this, having accurate attendee data from Vendelux gives you a distinct advantage. Use the enriched conference attendee list to prioritize your highest-value targets and convert on-the-ground interactions into long-term scientific or commercial partnerships.
Timing Is Everything
The ESMO Targeted Anticancer Therapies Congress 2026 takes place on March 16, 2026. With the event occurring early in the year, outreach efforts should begin in Q4 2025 through early Q1 2026 to capture attention from decision-makers while budgets and program priorities are still being finalized.
Using Vendelux, teams can access predictive insights into confirmed and likely attendees before the general list becomes available. This allows sales, marketing, and partnership leads to coordinate messaging aligned to interests, set appointments in advance, and develop high-relevance conversations that reflect each attendee’s focus. Early access to attendee data also enables more effective allocation of event resources, showroom presence, or private meeting spaces.
What’s Included In The ESMO Targeted Anticancer Therapies Congress 2026 Attendee List?
Vendelux provides visibility into expected attendees at ESMO Targeted Anticancer Therapies Congress 2026 through a combination of organizer-sourced data and predictive modeling. Clients can upload a list of strategic accounts to identify matches among the attendee base, surfacing high-potential connections in advance of the event.
The enriched list includes first and last names, job titles, company names, company websites, locations (city, state, country), LinkedIn profile URLs, verified email addresses, and where available, phone numbers. This level of detail supports personalized engagement and helps your team build relevant outreach sequences that extend across pre-event planning, on-site conversations, and continued post-conference communications.
Where Is ESMO Targeted Anticancer Therapies Congress 2026?
The congress will take place at Palais des Congrès in Paris, located in Paris, Île-de-France, France.
When Is ESMO Targeted Anticancer Therapies Congress 2026?
The event is scheduled for March 16, 2026.
What Type Of Event Is ESMO Targeted Anticancer Therapies Congress 2026?
ESMO Targeted Anticancer Therapies Congress 2026 is a scientific and industry-focused oncology event centered on the development and clinical application of targeted therapies. The program includes expert-led sessions, keynote presentations from research and industry leaders, scientific panels, poster sessions, and structured networking opportunities aimed at biotech and pharma professionals.
How Many People Attend ESMO Targeted Anticancer Therapies Congress 2026?
The congress typically draws over 1,000 participants from more than 40 countries. Attendees include senior-level professionals from the pharmaceutical industry, academic research centers, government health agencies, and biotech firms. Many hold decision-making roles across clinical development, regulatory science, research strategy, and corporate investment.
